Bioactivity evaluation of secondary metabolites produced by species of Tubeufiaceae

Cui FAN,Yong-Zhong LU,Ji-Chuan KANG,Lu WANG,Bang-Xing LEI,Li-Zhuang CHEN
DOI: https://doi.org/10.13346/j.mycosystema.180316
2019-01-01
Abstract:Secondary metabolites of fungi belonging to Tubeufiaceae are still imperfectly known. Through plate confrontation culture, colony growth rate determination and MTT method, 19 tubeufiaceous living strains and their fermentation substances were tested for observation of antifungal activities. The inhibition rate (IBR) of the crude fermentation extract against different cell lines of human tumors was also determined. Thirteen strains with obvious bioactivity were obtained. The strain Tubeufia rubra PF02-2 showed notable antifungal effects against seven plant pathogenic fungi with IBR over 60% and widest antifungal spectrum. The fermentation broth of Tubeufia rubra PF02-2 had certain inhibition effect on four plant pathogenic fungi. The ethyl acetate extract of mycelia exhibited excellent inhibition effect on potato early blight pathogen Alternaria solani. MTT assay indicated that crude extract of the fermentation broth of different fungal strains showed various degrees of cytotoxic activity against three human tumor cells. At 300μg/mL, the IBR (%) of ethyl acetate extract of Tubeufia machaerinae ML03-2 fermentation broth against human cervical cancer cell line HeLa cells and human prostate cancer cell line PC-3 cells reached 98.92±0.15 and 97.86±0.18, respectively, and at 400μg/mL, the IBR (%) of the extract against human hepatoma cell line HEPG2 cells reached 98.88±0.04. At 500μg/mL, the IBR (%) of Neohelicosporium hyalosporum ML05-1 mycelium ethyl acetate extract against human cervical cancer cell line HeLa cells was 98.32±0.02; at 600μg/mL, the IBR (%) of the extract against human liver cancer cell line HEPG2 cells reached 97.62±0.20, and at 300μg/mL, the IBR (%) against human prostate cancer cell line PC-3 cells was 98.91±0.02. The results of this study provide reference data for potential application value of tubeufiaceous fungi and the development possibility through pharmaceutical agrochemical industry.
What problem does this paper attempt to address?